Amgen (AMGN) Retained Earnings (2009 - 2026)

Amgen has reported Retained Earnings for 18 years, with the latest figure at -$22.3 billion in Q2 2026.

• On a quarterly basis, Retained Earnings rose 13.35% year-over-year to -$22.3 billion in Q2 2026; TTM through Jun 2026 was -$22.3 billion, a 13.35% increase from a year earlier, with the FY2025 full-year figure at -$25.1 billion, up 9.0% from the prior year.
• Retained Earnings was -$22.3 billion for Q2 2026 at Amgen, up from -$24.7 billion in the prior quarter.
• The five-year high for Retained Earnings was -$22.3 billion in Q2 2026, with the low at -$29.6 billion in Q1 2022.
• Average Retained Earnings over 5 years is -$26.4 billion, with a median of -$26.7 billion recorded in 2023.
• The sharpest annual moves came in 2022 and 2026: Retained Earnings plunged 36.64% in 2022, then advanced 13.35% in 2026.
• Over 5 years, Retained Earnings stood at -$28.6 billion in 2022, then grew by 7.24% to -$26.5 billion in 2023, then declined by 3.92% to -$27.6 billion in 2024, then climbed by 9.0% to -$25.1 billion in 2025, then rose by 11.28% to -$22.3 billion in 2026.
• The last three Retained Earnings figures came in at -$22.3 billion (Q2 2026), -$24.7 billion (Q1 2026), and -$25.1 billion (Q4 2025), per Business Quant data.